多沙唑嗪
特拉唑嗪
医学
哌唑嗪
增生
泌尿科
阿替洛尔
坦索罗辛
内科学
妇科
血压
敌手
受体
作者
Rishabh Mathur,Sumanlata Nayak,R Sivaramakrishnan,Vikas Jain
出处
期刊:PubMed
日期:2014-09-01
卷期号:62 (9 Suppl): 40-4
被引量:11
摘要
Hypertension and benign prostatic hyperplasia (BPH) are common disorders of aging men. As the world population is aging these two diseases are becoming a significant public health problem worldwide. Approximately 30% of men treated for BPH have coexisting hypertension. The α-Adrenergic Blockers: Prazosin, Terazosin and Doxazosin are established agents in the therapy of hypertension, and are also effective drugs in the treatment of BPH. It is reasonable to use α-Adrenergic Blockers as the treatment of choice for men with hypertension and BPH.
科研通智能强力驱动
Strongly Powered by AbleSci AI